In the phase III trial of panitumumab, multiple ocular side effects were noticed including conjunctivitis, conjunctival hyperemia, increased lacrimation, and irritation . There is no specialized protocol to treat ocular toxicity secondary to panitumumab and treatment should be individualized and done by the ophthalmologist.
Cetuximab and panitumumab are medications that block these proteins. Cetuximab and panitumumab are given with chemotherapy or individually in people with cancer
to VECTIBIX (panitumumab) blockade of EGFR occurred in 92% (N Like all medicines, VECTIBIX can cause unwanted side effects. The
Serious side effects have been reported with panitumumab including the following: Serious skin and subcutaneous tissue reactions. Talk to your
What are the Important Side Effects of Panitumumab? Infusion related reaction. These are usually mild or moderate, but rarely, they can be more severe. You
Find information on Panitumumab (Vectibix) in Davis's Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action
Cetuximab and panitumumab are medications that block these proteins. Cetuximab and panitumumab are given with chemotherapy or individually in people with cancer
Panitumumab is used to treat cancer. It is given in the vein (IV). Possible Side Effects Tiredness Nausea Diarrhea (loose bowel movements) Rash Infection of skin around the nails Note: Each of the side effects above was reported in 20% or greater of patients treated with panitumumab. All possible side effects are not included.
Possible Side Effects of Panitumumab Nail and Skin Changes Fatigue Nausea and/or Vomiting Diarrhea Less common, but important side effects
Comments